Application of a pharmaceutical composition in the preparation of medicaments for treating senile dementia

Abstract

The invention belongs to the technical field of medicine, and relates to application of a medicine composition in preparing medicine curing senile dementia. The medicine composition comprises the following components: fried fleece-flower root, desertliving cistanche, radix salviae miltiorrhizae, hoantchy root, gingko leaves, epimedium, kudzuvine root, cacumen biotae, cortex albiziae, angelica, radix morindae officinalis, ginger and Chinese wolfberry. The medicine composition is a pure Chinese herbal preparation, follows the principle of strengthening the body resistance to eliminate pathogenic factors and treating both symptoms and root causes, uses all the components, plays the role of tonifying liver and kidney, nourishing and activating blood, expanding blood vessels, reducing phlegm for resuscitation, reducing blood sugar, blood fat and cholesterol, and improving blood circulation and brain flow rate, has a remarkable effect in curing senile dementia, is low in side effect, and has a wide medicine application prospect.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to the application of a pharmaceutical composition in the preparation of medicaments for treating senile dementia. Background technique [0002] With the improvement of living standards in modern society, people's average life expectancy is increasing year by year, and the aging phenomenon of the global population is serious. In recent years, various diseases of the elderly have plagued the health of the elderly, especially the increasing incidence of Alzheimer's disease, which has become the number one killer that endangers the health of the elderly. Alzheimer's disease is a neurodegenerative disease with insidious onset and progressive development. Clinically, it is characterized by memory impairment, aphasia, apraxia, agnosia, impairment of visuospatial skills, executive dysfunction, and changes in personality and behavior. With the development of the disease, patients will gradua...

AI Technical Summary

Problems solved by technology

[0003] At present, the research and development of drugs for the treatment of Alzheimer's disease has attracted great attention from the medical circles all over the world. With the in-depth research of the neurophysiology, biochemistry and pharmacology of the elderly, the research and development of drugs for the treatment of Alzheimer's disease has also made great progress. Progress, however, so far, the etiology and pathogenesis of Alzheimer's disease are still unclear, the main theory of the pathogenesis of Alzheimer's disease is the amyloid peptide hypothesis: the precipitation of condensed Aβ in the brain parenchyma initiates a pathological cascade, leading to nerve fiber Tangle formation, neuronal loss and manifestations of dementia

At present, the drugs for the treatment of Alzheimer's disease mainly include cholinesterase inhibitors, cerebral vasodilators, calcium antagonists, drugs to prevent Aβ deposition, inhibitors of β and γ secretion of myrrh, anti-inflammatory drugs, and drugs with potential anti-senile dementia effects. Natural ingredients, although the above drugs have shown certain curative effect in clinical application, there are serious and unavoidable side effects during long-term use

Images